Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis
- PMID: 1887826
- DOI: 10.1002/jbmr.5650060615
Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis
Abstract
Vertebral osteoporosis, a common disorder in elderly women, is characterized by a wide spectrum of bone turnover abnormalities on iliac crest biopsy. The level of bone formation can be assessed noninvasively by measuring serum osteocalcin, whereas conventional biochemical markers of bone resorption lack specificity and do not reflect bone resorption assessed from histology. We measured the urinary excretion of pyridinoline crosslinks Pyr and D-Pyr, a specific marker of bone and cartilage collagen degradation, along with serum osteocalcin and urinary hydroxyproline, in 36 elderly women with vertebral osteoporosis who had a simultaneous iliac crest biopsy. Urinary pyridinoline crosslinks, but not hydroxyproline, correlated significantly with histologic resorption, assessed by the osteoclast surface (r = 0.35, p less than 0.05 for Pyr; r = 0.46, p less than 0.01 for D-Pyr). In addition, Pyr and D-Pyr were correlated with the bone formation rate as well as serum osteocalcin, with correlation coefficients ranging from 0.69 to 0.80, p less than 0.0001. These data indicate that Pyr and D-Pyr are sensitive markers of bone turnover in elderly women with vertebral osteoporosis. The poor correlation between the level of urinary collagen crosslinks and histological assessment of bone resorption indicates the low sensitivity of iliac crest histomorphometry in the measurement of resorption rate of the skeleton.
Similar articles
-
Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.J Bone Miner Res. 1996 Mar;11(3):337-49. doi: 10.1002/jbmr.5650110307. J Bone Miner Res. 1996. PMID: 8852944
-
Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?J Bone Miner Res. 1997 Jan;12(1):78-88. doi: 10.1359/jbmr.1997.12.1.78. J Bone Miner Res. 1997. PMID: 9240729
-
Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.J Bone Miner Res. 1995 Mar;10(3):458-65. doi: 10.1002/jbmr.5650100318. J Bone Miner Res. 1995. PMID: 7785468 Clinical Trial.
-
[Biochemical markers of bone turnover : clinical usefulness in osteoporosis].Ann Biol Clin (Paris). 1999 Mar-Apr;57(2):137-48. Ann Biol Clin (Paris). 1999. PMID: 10210740 Review. French.
-
Biochemical markers of bone turnover.J Bone Miner Res. 1993 Dec;8 Suppl 2:S549-55. doi: 10.1002/jbmr.5650081323. J Bone Miner Res. 1993. PMID: 8122526 Review.
Cited by
-
Harmonised Australian Reference Intervals for Serum PINP and CTX in Adults.Clin Biochem Rev. 2014 Nov;35(4):237-42. Clin Biochem Rev. 2014. PMID: 25678728 Free PMC article. Review.
-
Bone and collagen turnover during treatment with inhaled dry powder budesonide and beclomethasone dipropionate.Arch Dis Child. 1995 Dec;73(6):524-7. doi: 10.1136/adc.73.6.524. Arch Dis Child. 1995. PMID: 8546510 Free PMC article. Clinical Trial.
-
Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis.Osteoporos Int. 2010 Dec;21(12):2027-36. doi: 10.1007/s00198-009-1168-7. Epub 2010 Feb 5. Osteoporos Int. 2010. PMID: 20135094 Clinical Trial.
-
Osteocalcin, growth, and inhaled corticosteroids: a prospective study.Arch Dis Child. 1996 Jun;74(6):497-501. doi: 10.1136/adc.74.6.497. Arch Dis Child. 1996. PMID: 8758124 Free PMC article. Clinical Trial.
-
Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption.Osteoporos Int. 1993 Sep;3(5):255-60. doi: 10.1007/BF01623829. Osteoporos Int. 1993. PMID: 8400607
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources